Research situation of continuous pharmaceutical care at home and abroad
- VernacularTitle:国内外连续性药学服务的研究现状
- Author:
Xinyi CHEN
1
;
Han XIE
2
;
Weihong GE
3
;
Xin LI
4
Author Information
1. Drum Tower Clinical College of Nanjing Medical University，Nanjing 210008，China;School of Pharmacy，Nanjing Medical University，Nanjing 211166，China
2. Dept. of Pharmacy，the Affiliated Drum Tower Hospital，Medical College of Nanjing University，Nanjing 210008，China
3. Drum Tower Clinical College of Nanjing Medical University，Nanjing 210008，China;Dept. of Pharmacy，the Affiliated Drum Tower Hospital，Medical College of Nanjing University，Nanjing 210008，China
4. School of Pharmacy，Nanjing Medical University，Nanjing 211166，China
- Publication Type:Journal Article
- Keywords:
continuous pharmaceutical care;
medical consortium;
present situation research
- From:
China Pharmacy
2022;33(24):3063-3066
- CountryChina
- Language:Chinese
-
Abstract:
With the aging of Chinese society and the deepening of the reform of the medical and health system， pharmaceutical professionals are committed to providing patient-centered， efficient and scientific pharmaceutical care. Continuous pharmaceutical care has become the focus of scholars in this field. In this paper， the concept， importance， dimensions and evaluation indicators of continuous pharmaceutical care， as well as the development status at home and abroad， are reviewed by literature research， and suggestions for development are put forward. The continuous pharmaceutical care has been relatively mature in some developed countries. But in China， due to its late development， it is urgent to explore and develop evaluation indicators suitable for China’s medical and health service system. The continuous pharmaceutical care in China is mainly based on the coordination between comprehensive medical institutions and primary medical institutions within the medical consortium， achieves orderly two-way referral between medical institutions according to the individual situation of patients， and provides individualized drug treatment management for patients during disease prevention， treatment and after treatment.It is suggested to homogenize the pharmaceutical care of medical institutions at different levels， promote the cooperation among the government， medical insurance， superior medical institutions， etc.， so as to improve the pharmaceutical care of primary medical institutions and accelerate the construction of a continuous pharmaceutical care system.
